QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aptorum-group-announces-2m-registered-direct-offering-of-1m-shares-at-2-each-plus-4m-upside-from-2m-unregistered-warrants-in-concurrent-private-placement

$2 million upfront with up to additional $4 million of potential aggregate gross proceeds upon the exercise in full of warrants...

 stock-market-today-dow-sp-500-futures-rise-as-wall-street-awaits-powells-jackson-hole-keynoteazitra-zoom-among-top-movers-updated

U.S. stock futures rose on Friday following Thursday's declines. Futures of major benchmark indices were higher.

 aptorum-group-stock-sinks-after-hours-following-235-thursday-surge

Aptorum Group Limited (NASDAQ: APM) shares dropped 33.18% in Friday's pre-market trading after soaring 234.65% the previous...

 why-is-nano-cap-aptorum-stock-rallying-on-thursday

Aptorum stock rises after DiamiR Biosciences secures New York approval for its APOE Genotyping test ahead of a planned merger.

Core News & Articles

WMT: -4% | Walmart shares are trading lower following mixed Q2 financial results. APM: 69% | DiamiR's APOE Genotyping Test ...

 diamirs-apoe-genotyping-test-receives-clep-approval-from-new-york-state-department-of-health

DiamiR Biosciences Corp. ("DiamiR"), a developer of innovative blood-based diagnostic tests for brain health and other ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION